ReviewHeliyon2024
A comprehensive review of transduction methods of lectin-based biosensors in biomedical applications.
Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Utilization of nanosensors and nanomaterials to revolutionize the food industry: boosting product safety, quality, and sustainability.RSC advances · 2026Review
- Fluorescent carbon dot-based biosensor for the rapid and sensitive detection of Escherichia coli DNA.Scientific reports · 2026Article
- Glycosylation of Extracellular Vesicles: Analytical and Translational Insights into Biomarker Discovery and Regenerative Medicine.International journal of molecular sciences · 2026Review
- Detection of Premalignant Cervical Lesions viaBiosensors · 2025Article
- Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies.ACS bio & med chem Au · 2025Review
- Point-of-care biosensors for infectious disease diagnosis: recent updates and prospects.RSC advances · 2025Review
- Reduced graphene oxide-based absorbance biosensors for detecting Escherichia coli DNA.Scientific reports · 2025Article
- Integrated Photonic Biosensors: Enabling Next-Generation Lab-on-a-Chip Platforms.Nanomaterials (Basel, Switzerland) · 2025Review
- Advancements in Electrochemical Biosensors for Comprehensive Glycosylation Assessment of Biotherapeutics.Sensors (Basel, Switzerland) · 2025Review
- Toward spatial glycomics and glycoproteomics: Innovations and applications.BBA advances · 2025Article
- F-type lectins: Structural and functional aspects, and potential biomedical applications.BBA advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosensors have emerged as a pivotal technology in the biomedical field, significantly enhancing the rapidity and precision of biomolecule detection. These advancements are instrumental in refining diagnostic processes, optimizing treatments, and monitoring diseases more effectively. Central to the development of highly sensitive, selective, and stable biosensors are the bioreceptor and transducer components. This review paper discusses the use of lectin as a bioreceptor and explores the prevalent transducer methods employed in lectin-based biosensors, with a particular emphasis on their applications in biomedical research. The paper meticulously examines various transducers, with a spotlight on electrochemical and optical transduction methods, drawing from a wealth of previous studies to offer a comprehensive perspective on the application of these sensors in critical biomedical areas. These areas include early diagnosis, therapeutic interventions, and continuous health monitoring. Moreover, the review addresses the challenges of implementing lectin-based biosensors, such as specificity and stability issues. It also explores future possibilities, examining potential trends to overcome these challenges. In summary, this comprehensive analysis aspires to equip researchers with profound insights into the transformative potential of lectin-based biosensors, underscoring their significant role in the evolution of biomedical research and the broader healthcare landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.